SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea · Delayed Price · Currency is KRW 1,969.00
0.00 (0.00%)
At close: Oct 10, 2025
SLS BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
Net Income | -1,537 | 335.63 | 1,434 | 2,826 | 204.47 | 321.8 |
Depreciation & Amortization | 1,319 | 1,336 | 1,278 | 1,303 | 616.03 | 660.07 |
Loss (Gain) From Sale of Assets | -0.14 | 0 | 0.01 | -40.3 | -4 | - |
Loss (Gain) on Equity Investments | - | - | 39.06 | 236.35 | - | - |
Stock-Based Compensation | 1.62 | 3.75 | 11.77 | 32.79 | - | - |
Provision & Write-off of Bad Debts | -0.05 | 77.64 | 133.87 | 34.87 | 21.57 | - |
Other Operating Activities | 903.84 | 467.69 | -139.84 | -278.15 | 324.4 | 382.99 |
Change in Accounts Receivable | 1,046 | 118.11 | 1,076 | -202.97 | -564.81 | -604.44 |
Change in Inventory | 8.64 | 8.64 | 74.96 | -99.5 | - | - |
Change in Accounts Payable | -297.45 | -472.39 | 339.59 | 82.83 | 14.99 | -34.4 |
Change in Other Net Operating Assets | -510.85 | -149.13 | -812.36 | 138.74 | 112.13 | 154.94 |
Operating Cash Flow | 933.2 | 1,726 | 3,436 | 4,034 | 724.79 | 880.96 |
Operating Cash Flow Growth | -68.66% | -49.76% | -14.83% | 456.58% | -17.73% | - |
Capital Expenditures | -1,460 | -1,456 | -1,274 | -719.23 | -627.13 | -35.08 |
Sale of Property, Plant & Equipment | 0.2 | - | - | 203.64 | 4 | - |
Sale (Purchase) of Intangibles | -5.99 | -43.37 | -134.44 | -15.39 | -348.6 | -488.51 |
Investment in Securities | 1,494 | 997.32 | -6,509 | -1,012 | -1,499 | - |
Other Investing Activities | -15 | -0 | -0.78 | -0.52 | -71.52 | 2 |
Investing Cash Flow | 13.86 | -502.34 | -7,918 | -1,543 | -2,538 | -516.99 |
Short-Term Debt Issued | - | - | - | - | - | 320 |
Long-Term Debt Issued | - | - | - | - | 200 | - |
Total Debt Issued | - | - | - | - | 200 | 320 |
Short-Term Debt Repaid | - | - | - | -1,770 | -312 | -12 |
Long-Term Debt Repaid | - | -589.58 | -579.91 | -574.71 | -1,124 | -607.95 |
Total Debt Repaid | -596.4 | -589.58 | -579.91 | -2,345 | -1,436 | -619.95 |
Net Debt Issued (Repaid) | -596.4 | -589.58 | -579.91 | -2,345 | -1,236 | -299.95 |
Issuance of Common Stock | - | - | 5,660 | - | 3,626 | - |
Repurchase of Common Stock | -899.88 | -899.88 | - | - | - | - |
Dividends Paid | - | -383.71 | - | - | - | - |
Other Financing Activities | -27.8 | -27.8 | -302.2 | - | -187.77 | -26 |
Financing Cash Flow | -1,524 | -1,901 | 4,777 | -2,345 | 2,203 | -325.95 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 | - | - |
Net Cash Flow | -577.01 | -677.09 | 294.84 | 146.05 | 389.11 | 38.02 |
Free Cash Flow | -526.47 | 269.92 | 2,162 | 3,315 | 97.66 | 845.88 |
Free Cash Flow Growth | - | -87.51% | -34.79% | 3294.14% | -88.45% | - |
Free Cash Flow Margin | -7.22% | 3.22% | 23.96% | 30.83% | 1.57% | 14.53% |
Free Cash Flow Per Share | -34.57 | 17.66 | 153.75 | 483.26 | 19.58 | 194.51 |
Cash Interest Paid | - | - | - | 23.37 | 175.57 | 198.4 |
Cash Income Tax Paid | - | 36.53 | 6.47 | 1.09 | 3.06 | -0.02 |
Levered Free Cash Flow | 52.36 | -3.66 | 1,255 | - | -559.57 | - |
Unlevered Free Cash Flow | 99.57 | 48.79 | 1,318 | - | -349.34 | - |
Change in Working Capital | 246.04 | -494.76 | 678.68 | -80.9 | -437.68 | -483.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.